In summary, this study preliminarily indicates via network pharmacology and proteomics that ZGP may ameliorate the hormonal disturbances of PCOS by suppressing the phosphorylation of JNK/ERK, key nodes within the MAPK pathway. Here, MAPK8 is linked to polycystic ovary syndrome.